ClinicalTrials.Veeva

Menu

National Cohort of Children Born to HIV-positive Mothers (EPF)

A

ANRS, Emerging Infectious Diseases

Status

Unknown

Conditions

Mother to Child Transmission of HIV

Study type

Observational

Funder types

Other

Identifiers

NCT03306251
ANRS-CO11-EPF

Details and patient eligibility

About

The purpose of this study is to provide a surveillance system to monitor changes in the rate of mother to child HIV transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.

Full description

The goal of the CO11 national cohort is to provide with CO1 a wider surveillance system to monitor changes in the rate of mother to child transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.

The CO11 EPF enrolle HIV infected women who delivery in maternity generally smaller than CO1 maternity (15 sites in Paris area, 35 in mainland France and 4 in the DOM).

Maternal clinical, biological and therapeutic data before and during pregnancy were collected at delivery, with simplified questionnaires.

The children are examined clinically and biologically at birth, 6, 12 and 24 months.

Enrollment

5,200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women >= 18 years
  • infected with HIV1 and/or HIV2

Exclusion criteria

  • guardianship or judicial or administrative detention

Trial contacts and locations

52

Loading...

Central trial contact

Josiane WARSZAWSKI; Maud BROSSARD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems